Literature DB >> 22339886

Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up.

Oscar Ruiz-Moreno, Pilar Calvo, Blanca Ferrández, Clemencia Torrón.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22339886     DOI： 10.1111/j.1755-3768.2011.02363.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  2 in total

Review 1.  Juvenile Macular Degenerations.

Authors:  Pablo Altschwager; Lucia Ambrosio; Emily A Swanson; Anne Moskowitz; Anne B Fulton
Journal:  Semin Pediatr Neurol       Date:  2017-05-23       Impact factor: 1.636

2.  Choroidal neovascularization secondary to Best's vitelliform macular dystrophy in two siblings of a Malay family.

Authors:  Koh Alisa-Victoria; Tan Jin-Poi; Ismail Shatriah; Embong Zunaina; Nor Fariza Ngah
Journal:  Clin Ophthalmol       Date:  2014-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.